Linzess (linaclotide) is a prescription medication used to treat two specific conditions: irritable bowel syndrome with constipation (IBS-C) in adults and children 7 and older, and chronic idiopathic constipation (CIC) in adults. Both conditions involve persistent difficulty having bowel movements, but they differ in important ways, and Linzess is dosed differently for each.
The Two Conditions Linzess Treats
IBS-C is more than just constipation. It involves recurring abdominal pain directly tied to bowel movements, along with bloating, straining, and a feeling of incomplete emptying. The “with constipation” part distinguishes it from other forms of IBS that cause diarrhea or alternate between the two. People with IBS-C often deal with these symptoms for months or years before seeking prescription treatment.
Chronic idiopathic constipation (CIC) is persistent constipation that has no identifiable underlying cause. “Idiopathic” simply means doctors have ruled out other explanations like thyroid problems, medication side effects, or structural issues. CIC generally involves fewer than three spontaneous bowel movements per week, hard stools, and straining. The key difference from IBS-C is that CIC doesn’t typically come with the significant abdominal pain and bloating that define irritable bowel syndrome.
How Linzess Works
Linzess works locally in the gut rather than being absorbed into the bloodstream. It activates receptors on the inner lining of the intestines, which triggers two things: it increases fluid secretion into the intestines (softening stool and making it easier to pass) and it speeds up how quickly contents move through the digestive tract. For people with IBS-C, this same mechanism also reduces the heightened pain signaling from the gut nerves, which is why it helps with abdominal pain and not just constipation.
What to Expect With Timing and Results
Linzess is taken once daily on an empty stomach, at least 30 minutes before the first meal of the day. This timing matters because food can affect how the medication works and may increase the chance of side effects. The capsule should be swallowed whole.
In clinical trials, the median time to achieve three complete spontaneous bowel movements per week was about 4 weeks. Some people respond faster, while roughly 1 in 10 patients who ultimately benefit are “late responders” who see improvement between weeks 4 and 12. This means it’s worth giving the medication a fair trial before deciding it isn’t working.
The American Gastroenterological Association recommends linaclotide for adults with chronic idiopathic constipation who haven’t gotten adequate relief from over-the-counter options like fiber supplements, stool softeners, or osmotic laxatives. It’s positioned as a next step when those first-line approaches fall short.
Dosing Differences by Condition
The dose depends on which condition is being treated. For IBS-C, the standard dose is 290 mcg once daily. For chronic idiopathic constipation, it’s 145 mcg once daily. Your prescriber chooses the dose based on your diagnosis, not your body size or age. The higher IBS-C dose reflects the need to address both the pain and motility components of that condition.
Diarrhea and Other Side Effects
Diarrhea is the most common side effect by a wide margin, and it’s worth understanding before starting the medication. In IBS-C trials, 20% of patients taking Linzess experienced diarrhea compared to 3% on placebo. In CIC trials, the rate was 16% versus 5% on placebo. For most people, this diarrhea is mild to moderate, but in some cases it can be severe enough to require stopping the medication.
The diarrhea tends to occur early in treatment, often within the first two weeks. It’s more common when Linzess is taken with food, which is one reason the empty-stomach instruction exists. Other reported side effects include gas, bloating, and abdominal pain, though these occur at much lower rates than diarrhea.
Who Should Not Take Linzess
Linzess should not be used in children under 2 years old. It carries a boxed warning against use in children ages 2 through 6 based on safety concerns observed in young animal studies. For children 7 and older, it is approved only for IBS-C, not for general constipation. Adults with a known or suspected mechanical bowel obstruction (a physical blockage in the intestines) should also avoid the medication, since increasing fluid and motility in a blocked intestine could be dangerous.
People who have had a severe allergic reaction to linaclotide or any ingredient in the capsule should not take it. If you develop unusually severe or persistent diarrhea after starting Linzess, that’s a signal to contact your prescriber rather than push through it.